109:@0.890183:0.033217:0.921227:0.033217:0.921227:0.013052:0.890183:0.013052:0.010348:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056390:0.958557:0.056390:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158618:-0.158618:0.000000:0.000000:0.000000:0.000000:0.242660:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
ultimately led to  the  development of  these  agents.  :@0.076190:0.084931:0.485140:0.084931:0.485140:0.069149:0.076190:0.069149:0.009192:0.003024:0.005125:0.003024:0.014182:0.010326:0.005125:0.009827:0.003024:0.008104:0.007499:0.003024:0.009827:0.010357:0.007499:0.005125:0.009903:0.004188:0.003296:0.005125:0.009223:0.009827:0.004188:0.003296:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.014182:0.009827:0.009223:0.005125:0.007499:0.009903:0.004747:0.004188:0.003296:0.005125:0.009223:0.009827:0.005866:0.009827:0.004188:0.003296:0.010326:0.010175:0.009827:0.009223:0.005125:0.005866:0.004188:0.009731:0.004188
29:@0.471233:0.079633:0.480949:0.079633:0.480949:0.070479:0.471233:0.070479:0.004858:0.004858
These  agents  may not  only  improve  cognitive  symp-:@0.076185:0.099121:0.480922:0.099121:0.480922:0.083338:0.076185:0.083338:0.006441:0.009223:0.009827:0.005866:0.009827:0.004188:0.003492:0.010326:0.010175:0.009827:0.009223:0.005125:0.005866:0.004188:0.003492:0.014182:0.010326:0.008104:0.007696:0.009223:0.009903:0.005125:0.004188:0.003492:0.009903:0.009223:0.003024:0.008104:0.004188:0.003492:0.003024:0.014182:0.010311:0.004551:0.009903:0.008376:0.009827:0.004188:0.003492:0.009782:0.009903:0.010175:0.009223:0.003024:0.005125:0.003024:0.008376:0.009827:0.004188:0.003492:0.005866:0.008104:0.014182:0.010311:0.005020
toms, but may also result in improvement in associated :@0.076185:0.113310:0.485110:0.113310:0.485110:0.097527:0.076185:0.097527:0.005125:0.009903:0.014182:0.005866:0.004188:0.004762:0.010311:0.009192:0.005125:0.004762:0.014182:0.010326:0.008104:0.004762:0.010326:0.003024:0.005866:0.009903:0.004762:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.004762:0.003024:0.009223:0.004762:0.003024:0.014182:0.010311:0.004551:0.009903:0.008376:0.009827:0.014182:0.009827:0.009223:0.005125:0.004762:0.003024:0.009223:0.004762:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.004188
symptoms, including apathy, agitation, depression, and :@0.076185:0.127499:0.485140:0.127499:0.485140:0.111717:0.076185:0.111717:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004188:0.003825:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.003024:0.009223:0.010175:0.003825:0.010326:0.010311:0.010326:0.005125:0.009223:0.008104:0.004188:0.003825:0.010326:0.010175:0.003024:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.003825:0.010357:0.009827:0.010311:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.004188:0.003825:0.010326:0.009223:0.010357:0.004188
psychotic symptoms.  To  date, there  is no evidence :@0.076185:0.141689:0.485131:0.141684:0.485131:0.125902:0.076185:0.125906:0.010311:0.005866:0.008104:0.009782:0.009223:0.009903:0.005125:0.003024:0.009782:0.007605:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004188:0.009728:0.007605:0.006441:0.009903:0.004188:0.003402:0.010357:0.010326:0.005125:0.009827:0.004188:0.007605:0.005125:0.009223:0.009827:0.004551:0.009827:0.004188:0.003402:0.003024:0.005866:0.007605:0.009223:0.009903:0.007605:0.009827:0.008376:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.663709
30:@0.232645:0.136386:0.242361:0.136386:0.242361:0.127232:0.232645:0.127232:0.004858:0.004858
suggesting that any one of the cholinesterase inhibitors :@0.076191:0.155874:0.485116:0.155874:0.485116:0.140091:0.076191:0.140091:0.005866:0.009192:0.010175:0.010175:0.009827:0.005866:0.005125:0.003024:0.009223:0.010175:0.004596:0.005125:0.009223:0.010326:0.005125:0.004596:0.010326:0.009223:0.008104:0.004611:0.009903:0.009223:0.009827:0.004596:0.009903:0.004747:0.004596:0.005125:0.009223:0.009827:0.004596:0.009782:0.009223:0.009903:0.003024:0.003024:0.009223:0.009827:0.005866:0.005125:0.009827:0.004551:0.010326:0.005866:0.009827:0.004596:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.004188
is more effective than another, and the choice should :@0.076191:0.170063:0.485146:0.170063:0.485146:0.154280:0.076191:0.154280:0.003024:0.005866:0.005337:0.014182:0.009903:0.004551:0.009827:0.005337:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.005337:0.005125:0.009223:0.010326:0.009223:0.005337:0.010326:0.009223:0.009903:0.005125:0.009223:0.009827:0.004551:0.004188:0.005322:0.010326:0.009223:0.010357:0.005337:0.005125:0.009223:0.009827:0.005337:0.009782:0.009223:0.009903:0.003024:0.009782:0.009827:0.005337:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004188
be made based on cost and side-effect profile.:@0.076191:0.184252:0.424050:0.184252:0.424050:0.168470:0.076191:0.168470:0.010311:0.009827:0.004188:0.014182:0.010326:0.010357:0.009827:0.004188:0.010311:0.010326:0.005866:0.009827:0.010357:0.004188:0.009903:0.009223:0.004188:0.009782:0.009903:0.005866:0.005125:0.004188:0.010326:0.009223:0.010357:0.004188:0.005866:0.003024:0.010357:0.009827:0.005020:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.004188:0.010311:0.004551:0.009903:0.003681:0.003681:0.003024:0.009827:0.004188
31,32:@0.424024:0.178950:0.445885:0.178950:0.445885:0.169796:0.424024:0.169796:0.004858:0.004858:0.002429:0.004858:0.004858
 :@0.445891:0.184249:0.450079:0.184249:0.450079:0.168466:0.445891:0.168466:0.004188
A second class of molecule is available for more se-:@0.090473:0.198438:0.480952:0.198438:0.480952:0.182656:0.090473:0.182656:0.011188:0.005579:0.005866:0.009827:0.009782:0.009903:0.009223:0.010357:0.005579:0.009782:0.003024:0.010326:0.005866:0.005866:0.005594:0.009903:0.004747:0.005579:0.014182:0.009903:0.003024:0.009827:0.009782:0.009192:0.003024:0.009827:0.005579:0.003024:0.005866:0.005579:0.010326:0.008376:0.010326:0.003024:0.003024:0.010326:0.010311:0.003024:0.009827:0.005594:0.004747:0.009903:0.004551:0.005579:0.014182:0.009903:0.004551:0.009827:0.005564:0.005866:0.009827:0.005020
vere AD. The NMDA receptor antagonist memantine has :@0.076185:0.212628:0.485125:0.212628:0.485125:0.196845:0.076185:0.196845:0.008376:0.009827:0.004551:0.009827:0.002857:0.011188:0.011249:0.004188:0.002857:0.006441:0.009223:0.009827:0.002857:0.011188:0.013894:0.011249:0.011188:0.002857:0.004551:0.009827:0.009782:0.009827:0.010311:0.005125:0.009903:0.004551:0.002842:0.010326:0.009223:0.005125:0.010326:0.010175:0.009903:0.009223:0.003024:0.005866:0.005125:0.002857:0.014182:0.009827:0.014182:0.010326:0.009223:0.005125:0.003024:0.009223:0.009827:0.002857:0.009223:0.010326:0.005866:0.004188
been regis tered in Europe and the UsA for more than :@0.076185:0.226817:0.485140:0.226817:0.485140:0.211034:0.076185:0.211034:0.010311:0.009827:0.009827:0.009223:0.006002:0.004551:0.009827:0.010175:0.003024:0.005866:0.000000:0.005125:0.009827:0.004551:0.009827:0.010357:0.006002:0.003024:0.009223:0.006017:0.008104:0.009192:0.004551:0.009903:0.010311:0.009827:0.006002:0.010326:0.009223:0.010357:0.006017:0.005125:0.009223:0.009827:0.006002:0.009903:0.007529:0.011188:0.006002:0.004747:0.009903:0.004551:0.006002:0.014182:0.009903:0.004551:0.009827:0.006002:0.005125:0.009223:0.010326:0.009223:0.004188
10 years for this indication. It has benefits for improving :@0.076185:0.241006:0.485125:0.241006:0.485125:0.225224:0.076185:0.225224:0.008376:0.008376:0.005140:0.008104:0.009827:0.010326:0.004551:0.005866:0.005140:0.004747:0.009903:0.004551:0.005125:0.005125:0.009223:0.003024:0.005866:0.005140:0.003024:0.009223:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.005140:0.003417:0.005125:0.005140:0.009223:0.010326:0.005866:0.005140:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.005866:0.005125:0.004747:0.009903:0.004551:0.005125:0.003024:0.014182:0.010311:0.004551:0.009903:0.008376:0.003024:0.009223:0.010175:0.004188
agitation and BpsD, as well as slowing cognitive decline :@0.076185:0.255196:0.485125:0.255196:0.485125:0.239413:0.076185:0.239413:0.010326:0.010175:0.003024:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.003734:0.010326:0.009223:0.010357:0.003734:0.008678:0.008950:0.007529:0.011249:0.004188:0.003734:0.010326:0.005866:0.003734:0.012564:0.009827:0.003024:0.003024:0.003734:0.010326:0.005866:0.003734:0.005866:0.003024:0.009903:0.012564:0.003024:0.009223:0.010175:0.003734:0.009782:0.009903:0.010175:0.009223:0.003024:0.005125:0.003024:0.008376:0.009827:0.003734:0.010357:0.009827:0.009782:0.003024:0.003024:0.009223:0.009827:0.004188
and reducing caregiver burden.  More recently, there :@0.076185:0.269385:0.485161:0.269378:0.485161:0.253596:0.076185:0.253602:0.010326:0.009223:0.010357:0.005095:0.004551:0.009827:0.010357:0.009192:0.009782:0.003024:0.009223:0.010175:0.005095:0.009782:0.010326:0.004551:0.009827:0.010175:0.003024:0.008376:0.009827:0.004551:0.005095:0.010311:0.009192:0.004551:0.010357:0.009827:0.009223:0.004188:0.009712:0.005095:0.013894:0.009903:0.004551:0.009827:0.005095:0.004551:0.009827:0.009782:0.009827:0.009223:0.005125:0.003024:0.008104:0.004188:0.005095:0.005125:0.009223:0.009827:0.004551:0.009827:0.496461
33:@0.315588:0.264080:0.325304:0.264080:0.325304:0.254926:0.315588:0.254926:0.004858:0.004858
have been  trials to  suggest  that  memantine  may be :@0.076191:0.283568:0.485116:0.283568:0.485116:0.267785:0.076191:0.267785:0.009223:0.010326:0.008376:0.009827:0.007151:0.010311:0.009827:0.009827:0.009223:0.004188:0.002948:0.005125:0.004551:0.003024:0.010326:0.003024:0.005866:0.007151:0.005125:0.009903:0.004188:0.002948:0.005866:0.009192:0.010175:0.010175:0.009827:0.005866:0.005125:0.004188:0.002948:0.005125:0.009223:0.010326:0.005125:0.004188:0.002948:0.014182:0.009827:0.014182:0.010326:0.009223:0.005125:0.003024:0.009223:0.009827:0.004188:0.002948:0.014182:0.010326:0.008104:0.007151:0.010311:0.009827:0.004188
introduced in earlier disease, together with cholinester-:@0.076191:0.297757:0.480943:0.297757:0.480943:0.281974:0.076191:0.281974:0.003024:0.009223:0.005125:0.004551:0.009903:0.010357:0.009192:0.009782:0.009827:0.010357:0.004778:0.003024:0.009223:0.004778:0.009827:0.010326:0.004551:0.003024:0.003024:0.009827:0.004551:0.004778:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188:0.004793:0.005125:0.009903:0.010175:0.009827:0.005125:0.009223:0.009827:0.004551:0.004762:0.012564:0.003024:0.005125:0.009223:0.004778:0.009782:0.009223:0.009903:0.003024:0.003024:0.009223:0.009827:0.005866:0.005125:0.009827:0.004551:0.005020
ase inhibitors, and that together these agents may be :@0.076191:0.311946:0.485131:0.311946:0.485131:0.296164:0.076191:0.296164:0.010326:0.005866:0.009827:0.005594:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.004188:0.005579:0.010326:0.009223:0.010357:0.005579:0.005125:0.009223:0.010326:0.005125:0.005579:0.005125:0.009903:0.010175:0.009827:0.005125:0.009223:0.009827:0.004551:0.005564:0.005125:0.009223:0.009827:0.005866:0.009827:0.005579:0.010326:0.010175:0.009827:0.009223:0.005125:0.005866:0.005579:0.014182:0.010326:0.008104:0.005594:0.010311:0.009827:0.004188
well tolerated.  :@0.076191:0.326136:0.194972:0.326131:0.194972:0.310349:0.076191:0.310353:0.012564:0.009827:0.003024:0.003024:0.004188:0.005125:0.009903:0.003024:0.009827:0.004551:0.010326:0.005125:0.009827:0.010357:0.004188:0.009712:0.712331
34:@0.181064:0.320833:0.190780:0.320833:0.190780:0.311679:0.181064:0.311679:0.004858:0.004858
An  immediate barrier to  the use of these agents is :@0.090469:0.340321:0.485136:0.340321:0.485136:0.324538:0.090469:0.324538:0.011188:0.009223:0.004188:0.003024:0.003024:0.014182:0.014182:0.009827:0.010357:0.003024:0.010326:0.005125:0.009827:0.007227:0.010311:0.010326:0.004551:0.004551:0.003024:0.009827:0.004551:0.007227:0.005125:0.009903:0.004188:0.003024:0.005125:0.009223:0.009827:0.007227:0.009192:0.005866:0.009827:0.007227:0.009903:0.004747:0.007227:0.005125:0.009223:0.009827:0.005866:0.009827:0.007227:0.010326:0.010175:0.009827:0.009223:0.005125:0.005866:0.007227:0.003024:0.005866:0.004188
the expense. Nevertheless, by decreasing behavioural :@0.076181:0.354510:0.485106:0.354510:0.485106:0.338728:0.076181:0.338728:0.005125:0.009223:0.009827:0.005609:0.009827:0.007257:0.010311:0.009827:0.009223:0.005866:0.009827:0.004188:0.005609:0.011188:0.009827:0.008376:0.009827:0.004551:0.005125:0.009223:0.009827:0.003024:0.009827:0.005866:0.005866:0.004188:0.005609:0.010311:0.008104:0.005624:0.010357:0.009827:0.009782:0.004551:0.009827:0.010326:0.005866:0.003024:0.009223:0.010175:0.005609:0.010311:0.009827:0.009223:0.010326:0.008376:0.003024:0.009903:0.009192:0.004551:0.010326:0.003024:0.004188
symptoms and reducing hospitalisation and placement :@0.076181:0.368700:0.485121:0.368700:0.485121:0.352917:0.076181:0.352917:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004067:0.010326:0.009223:0.010357:0.004067:0.004551:0.009827:0.010357:0.009192:0.009782:0.003024:0.009223:0.010175:0.004067:0.009223:0.009903:0.005866:0.010311:0.003024:0.005125:0.010326:0.003024:0.003024:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.004082:0.010326:0.009223:0.010357:0.004067:0.010311:0.003024:0.010326:0.009782:0.009827:0.014182:0.009827:0.009223:0.005125:0.004188
costs,  these  medications  may actually be  cost-effec-:@0.076181:0.382889:0.480933:0.382889:0.480933:0.367106:0.076181:0.367106:0.009782:0.009903:0.005866:0.005125:0.005866:0.004188:0.004188:0.002842:0.005125:0.009223:0.009827:0.005866:0.009827:0.004188:0.002842:0.014182:0.009827:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.002842:0.014182:0.010326:0.008104:0.007045:0.010326:0.009782:0.005125:0.009192:0.010326:0.003024:0.003024:0.008104:0.007045:0.010311:0.009827:0.004188:0.002842:0.009782:0.009903:0.005866:0.005125:0.005020:0.009827:0.004747:0.004747:0.009827:0.009782:0.005020
tive.:@0.076181:0.397078:0.106722:0.397078:0.106722:0.381296:0.076181:0.381296:0.005125:0.003024:0.008376:0.009827:0.004188
35,36:@0.106731:0.391774:0.128592:0.391774:0.128592:0.382620:0.106731:0.382620:0.004858:0.004858:0.002429:0.004858:0.004858
 There is the additional benefit of the possibility :@0.128598:0.397073:0.485105:0.397073:0.485105:0.381290:0.128598:0.381290:0.005836:0.006441:0.009223:0.009827:0.004551:0.009827:0.005821:0.003024:0.005866:0.005836:0.005125:0.009223:0.009827:0.005821:0.010326:0.010357:0.010357:0.003024:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.005836:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.005821:0.009903:0.004747:0.005821:0.005125:0.009223:0.009827:0.005821:0.010311:0.009903:0.005866:0.005866:0.003024:0.010311:0.003024:0.003024:0.003024:0.005125:0.008104:0.004188
that caregiver burden may be considerably lightened.  :@0.076195:0.411262:0.485140:0.411261:0.485140:0.395478:0.076195:0.395479:0.005125:0.009223:0.010326:0.005125:0.003387:0.009782:0.010326:0.004551:0.009827:0.010175:0.003024:0.008376:0.009827:0.004551:0.003387:0.010311:0.009192:0.004551:0.010357:0.009827:0.009223:0.003372:0.014182:0.010326:0.008104:0.003387:0.010311:0.009827:0.003387:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.010326:0.010311:0.003024:0.008104:0.003387:0.003024:0.003024:0.010175:0.009223:0.005125:0.009827:0.009223:0.009827:0.010357:0.004188:0.009711:0.310684
37:@0.471233:0.405962:0.480949:0.405962:0.480949:0.396808:0.471233:0.396808:0.004858:0.004858
No  good  quality data exist for  oestrogen  replace-:@0.090473:0.425450:0.480952:0.425450:0.480952:0.409668:0.090473:0.409668:0.011188:0.009903:0.004188:0.003870:0.010175:0.009903:0.009903:0.010357:0.004188:0.003870:0.010311:0.009192:0.010326:0.003024:0.003024:0.005125:0.008104:0.008074:0.010357:0.010326:0.005125:0.010326:0.008074:0.009827:0.007257:0.003024:0.005866:0.005125:0.008074:0.004747:0.009903:0.004551:0.004188:0.003870:0.009903:0.009827:0.005866:0.005125:0.004551:0.009903:0.010175:0.009827:0.009223:0.004188:0.003855:0.004551:0.009827:0.010311:0.003024:0.010326:0.009782:0.009827:0.005020
ment, vitamin E or NsAIDs in the treatment of AD.:@0.076185:0.439639:0.433705:0.439639:0.433705:0.423857:0.076185:0.423857:0.014182:0.009827:0.009223:0.005125:0.004188:0.004188:0.008376:0.003024:0.005125:0.010326:0.014182:0.003024:0.009223:0.004188:0.008104:0.004188:0.009903:0.004551:0.004188:0.011188:0.007529:0.011188:0.003417:0.011249:0.005866:0.004188:0.003024:0.009223:0.004188:0.005125:0.009223:0.009827:0.004188:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.009903:0.004747:0.004188:0.011188:0.011249:0.004188
38-40:@0.433658:0.434339:0.456002:0.434339:0.456002:0.425185:0.433658:0.425185:0.004858:0.004858:0.002911:0.004858:0.004858
 :@0.456009:0.439637:0.460197:0.439637:0.460197:0.423855:0.456009:0.423855:0.004188
steP 4: Assess resPOnse tO treAtment:@0.076190:0.472573:0.425810:0.472573:0.425810:0.452408:0.076190:0.452408:0.009609:0.007761:0.009609:0.010348:0.005174:0.010348:0.005174:0.005174:0.013674:0.009609:0.009609:0.009609:0.009609:0.009609:0.005174:0.010718:0.009609:0.009609:0.010348:0.015522:0.013674:0.009609:0.009609:0.005174:0.007761:0.015522:0.005174:0.007761:0.010718:0.009609:0.013674:0.007761:0.016631:0.009609:0.013674:0.007761
In order to determine response to medi cation, it is impor-:@0.076190:0.488539:0.480957:0.488539:0.480957:0.472756:0.076190:0.472756:0.003115:0.008920:0.004793:0.009601:0.004248:0.010054:0.009525:0.004248:0.004793:0.004823:0.009601:0.004793:0.010054:0.009525:0.004823:0.009525:0.004248:0.013879:0.002721:0.008920:0.009525:0.004793:0.004248:0.009525:0.005564:0.010009:0.009601:0.008920:0.005564:0.009525:0.004793:0.004823:0.009601:0.004793:0.013879:0.009525:0.010054:0.002721:0.000000:0.009480:0.010024:0.004823:0.002721:0.009601:0.008920:0.003886:0.004793:0.002721:0.004823:0.004793:0.002721:0.005564:0.004793:0.002721:0.013879:0.010009:0.009601:0.004248:0.005020
tant to set reasonable expectations for the patient’s re-:@0.076190:0.502728:0.480972:0.502728:0.480972:0.486946:0.076190:0.486946:0.004823:0.010024:0.008920:0.004823:0.006002:0.004823:0.009601:0.005987:0.005564:0.009525:0.004823:0.006002:0.004248:0.009525:0.010024:0.005564:0.009601:0.008920:0.010024:0.010009:0.002721:0.009525:0.005987:0.009525:0.006955:0.010009:0.009525:0.009480:0.004823:0.010024:0.004823:0.002721:0.009601:0.008920:0.005564:0.005987:0.004445:0.009601:0.004248:0.005987:0.004823:0.008920:0.009525:0.006002:0.010009:0.010024:0.004823:0.002721:0.009525:0.008920:0.004823:0.005004:0.005564:0.006002:0.004248:0.009525:0.005020
sponse to treatment. It may be useful to complete a scale, :@0.076190:0.516918:0.485085:0.516918:0.485085:0.501135:0.076190:0.501135:0.005564:0.010009:0.009601:0.008920:0.005564:0.009525:0.003190:0.004823:0.009601:0.003190:0.004823:0.004248:0.009525:0.010024:0.004823:0.013879:0.009525:0.008920:0.004823:0.003886:0.003190:0.003115:0.004823:0.003190:0.013879:0.010024:0.007801:0.003190:0.010009:0.009525:0.003190:0.008890:0.005564:0.009525:0.004445:0.008890:0.002721:0.003190:0.004823:0.009601:0.003190:0.009480:0.009601:0.013879:0.010009:0.002721:0.009525:0.004823:0.009525:0.003190:0.010024:0.003190:0.005564:0.009480:0.010024:0.002721:0.009525:0.004188:0.004188
such as the Mini Mental status Examination (see Table 2) in :@0.076190:0.531107:0.485160:0.531107:0.485160:0.515324:0.076190:0.515324:0.005564:0.008890:0.009480:0.008920:0.003417:0.010024:0.005564:0.003417:0.004823:0.008920:0.009525:0.003417:0.013592:0.002721:0.008920:0.002721:0.003417:0.013592:0.009525:0.008920:0.004823:0.010024:0.002721:0.003417:0.007227:0.004823:0.010024:0.004823:0.008890:0.005564:0.003417:0.007801:0.006955:0.010024:0.013879:0.002721:0.008920:0.010024:0.004823:0.002721:0.009601:0.008920:0.003417:0.005277:0.005564:0.009525:0.009525:0.003417:0.006138:0.010024:0.010009:0.002721:0.009525:0.003417:0.008074:0.005277:0.003417:0.002721:0.009223:0.004188
order to help quantify response to medication.  :@0.076190:0.545296:0.417122:0.545292:0.417122:0.529509:0.076190:0.529514:0.009601:0.004248:0.010054:0.009525:0.004248:0.003886:0.004823:0.009601:0.003886:0.008920:0.009525:0.002721:0.010009:0.003886:0.010009:0.008890:0.010024:0.008920:0.004823:0.002721:0.004445:0.007801:0.003886:0.004248:0.009525:0.005564:0.010009:0.009601:0.008920:0.005564:0.009525:0.003886:0.004823:0.009601:0.003886:0.013879:0.009525:0.010054:0.002721:0.009480:0.010024:0.004823:0.002721:0.009601:0.008920:0.004188:0.009204:0.203185
41:@0.403389:0.539993:0.412930:0.539993:0.412930:0.530839:0.403389:0.530839:0.004683:0.004858
side effects of the medication should also be moni-:@0.090475:0.559481:0.480924:0.559481:0.480924:0.543699:0.090475:0.543699:0.007529:0.003024:0.010357:0.009827:0.006002:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.006002:0.009903:0.004747:0.006002:0.005125:0.009223:0.009827:0.006002:0.014182:0.009827:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.006002:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.006002:0.010326:0.003024:0.005866:0.009903:0.006002:0.010311:0.009827:0.006002:0.014182:0.009903:0.009223:0.003024:0.005020
tored. Gastro-intestinal side effects are the most com-:@0.076187:0.573671:0.480939:0.573671:0.480939:0.557888:0.076187:0.557888:0.005125:0.009903:0.004551:0.009827:0.010357:0.004188:0.005881:0.013184:0.010326:0.005866:0.005125:0.004551:0.009903:0.005020:0.003024:0.009223:0.005125:0.009827:0.005866:0.005125:0.003024:0.009223:0.010326:0.003024:0.005896:0.005866:0.003024:0.010357:0.009827:0.005896:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.005881:0.010326:0.004551:0.009827:0.005881:0.005125:0.009223:0.009827:0.005881:0.014182:0.009903:0.005866:0.005125:0.005881:0.009782:0.009903:0.014182:0.005020
mon after cholinesterase inhibitors. They are dose-:@0.076187:0.587860:0.480969:0.587860:0.480969:0.572077:0.076187:0.572077:0.014182:0.009903:0.009223:0.010795:0.010326:0.004747:0.005125:0.009827:0.004551:0.010795:0.009782:0.009223:0.009903:0.003024:0.003024:0.009223:0.009827:0.005866:0.005125:0.009827:0.004551:0.010326:0.005866:0.009827:0.010795:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.004188:0.010795:0.006441:0.009223:0.009827:0.008104:0.010795:0.010326:0.004551:0.009827:0.010795:0.010357:0.009903:0.005866:0.009827:0.005020
related  and  often  transient,  and  may  be  particularly :@0.076187:0.602049:0.485112:0.602049:0.485112:0.586267:0.076187:0.586267:0.004551:0.009827:0.003024:0.010326:0.005125:0.009827:0.010357:0.004188:0.003311:0.010326:0.009223:0.010357:0.004188:0.003311:0.009903:0.004747:0.005125:0.009827:0.009223:0.004188:0.003311:0.005125:0.004551:0.010326:0.009223:0.005866:0.003024:0.009827:0.009223:0.005125:0.004188:0.004188:0.003311:0.010326:0.009223:0.010357:0.004188:0.003311:0.014182:0.010326:0.008104:0.004188:0.003311:0.010311:0.009827:0.004188:0.003311:0.010311:0.010326:0.004551:0.005125:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.003024:0.008104:0.004188
distressing for thin, small patients. patients who are in-:@0.076187:0.616239:0.480939:0.616239:0.480939:0.600456:0.076187:0.600456:0.010357:0.003024:0.005866:0.005125:0.004551:0.009827:0.005866:0.005866:0.003024:0.009223:0.010175:0.006410:0.004747:0.009903:0.004551:0.006410:0.005125:0.009223:0.003024:0.009223:0.004188:0.006410:0.005866:0.014182:0.010326:0.003024:0.003024:0.006426:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.006410:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006410:0.012564:0.009223:0.009903:0.006410:0.010326:0.004551:0.009827:0.006410:0.003024:0.009223:0.005020
tolerant of a particular cholinesterase inhibitor can be :@0.076187:0.630428:0.485142:0.630428:0.485142:0.614645:0.076187:0.614645:0.005125:0.009903:0.003024:0.009827:0.004551:0.010326:0.009223:0.005125:0.005730:0.009903:0.004747:0.005745:0.010326:0.005745:0.010311:0.010326:0.004551:0.005125:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.005745:0.009782:0.009223:0.009903:0.003024:0.003024:0.009223:0.009827:0.005866:0.005125:0.009827:0.004551:0.010326:0.005866:0.009827:0.005745:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005745:0.009782:0.010326:0.009223:0.005745:0.010311:0.009827:0.004188
switched to another.  :@0.076187:0.644617:0.241613:0.644610:0.241613:0.628827:0.076187:0.628835:0.005866:0.012564:0.003024:0.005125:0.009782:0.009223:0.009827:0.010357:0.004188:0.005125:0.009903:0.004188:0.010326:0.009223:0.009903:0.005125:0.009223:0.009827:0.004551:0.004188:0.009700:0.248635
42:@0.227706:0.639311:0.237422:0.639311:0.237422:0.630157:0.227706:0.630157:0.004858:0.004858
The cholinesterase inhibitors slow the rate of decline :@0.090483:0.658799:0.485135:0.658799:0.485135:0.643016:0.090483:0.643016:0.006441:0.009223:0.009827:0.005881:0.009782:0.009223:0.009903:0.003024:0.003024:0.009223:0.009827:0.005866:0.005125:0.009827:0.004551:0.010326:0.005866:0.009827:0.005896:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.005896:0.005866:0.003024:0.009903:0.012564:0.005896:0.005125:0.009223:0.009827:0.005881:0.004551:0.010326:0.005125:0.009827:0.005881:0.009903:0.004747:0.005896:0.010357:0.009827:0.009782:0.003024:0.003024:0.009223:0.009827:0.004188
of cognitive function and improve activities of daily liv-:@0.076196:0.672988:0.480963:0.672988:0.480963:0.657206:0.076196:0.657206:0.009903:0.004747:0.004853:0.009782:0.009903:0.010175:0.009223:0.003024:0.005125:0.003024:0.008376:0.009827:0.004853:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004853:0.010326:0.009223:0.010357:0.004868:0.003024:0.014182:0.010311:0.004551:0.009903:0.008376:0.009827:0.004868:0.010326:0.009782:0.005125:0.003024:0.008376:0.003024:0.005125:0.003024:0.009827:0.005866:0.004868:0.009903:0.004747:0.004853:0.010357:0.010326:0.003024:0.003024:0.008104:0.004868:0.003024:0.003024:0.008421:0.005020
ing , although individual patient response may be high-:@0.076196:0.687178:0.480947:0.687174:0.480947:0.671392:0.076196:0.671395:0.003024:0.009223:0.010175:0.004853:0.004188:0.004203:0.010326:0.003024:0.005125:0.009223:0.009903:0.009192:0.010175:0.009223:0.004188:0.003024:0.009223:0.010357:0.003024:0.008376:0.003024:0.010357:0.009192:0.010326:0.003024:0.004218:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.004203:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.005866:0.009827:0.004203:0.014182:0.010326:0.008104:0.004203:0.010311:0.009827:0.004203:0.009223:0.003024:0.010175:0.009223:-0.045607
5:@0.098611:0.681876:0.103469:0.681876:0.103469:0.672722:0.098611:0.672722:0.004858
ly heterogeneous and inde pendent of stage or severity :@0.076196:0.701364:0.485150:0.701364:0.485150:0.685581:0.076196:0.685581:0.003024:0.008104:0.004264:0.009223:0.009827:0.005125:0.009827:0.004536:0.009903:0.010175:0.009827:0.009223:0.009827:0.009888:0.009192:0.005866:0.004264:0.010326:0.009223:0.010357:0.004264:0.003024:0.009223:0.010357:0.009827:0.000000:0.010311:0.009827:0.009223:0.010357:0.009827:0.009223:0.005125:0.004264:0.009903:0.004747:0.004264:0.005866:0.005125:0.010326:0.010175:0.009827:0.004264:0.009903:0.004551:0.004248:0.005866:0.009827:0.008376:0.009827:0.004551:0.003024:0.005125:0.008104:0.004188
of  illness.  Improvement  may be noted  by caregiver :@0.076196:0.715553:0.485157:0.715551:0.485157:0.699768:0.076196:0.699770:0.009903:0.004747:0.004188:0.003145:0.003024:0.003024:0.003024:0.009223:0.009827:0.005866:0.005866:0.004188:0.009729:0.007348:0.003417:0.014182:0.010311:0.004551:0.009903:0.008376:0.009827:0.014182:0.009827:0.009223:0.005125:0.004188:0.003145:0.014182:0.010326:0.008104:0.007348:0.010311:0.009827:0.007348:0.009223:0.009903:0.005125:0.009827:0.010357:0.004188:0.003145:0.010311:0.008104:0.007348:0.009782:0.010326:0.004551:0.009827:0.010175:0.003024:0.008376:0.009827:0.004551:-0.087809
43:@0.142229:0.710252:0.151946:0.710252:0.151946:0.701098:0.142229:0.701098:0.004858:0.004858
reports, but also by improved or stabilised MMsE scores; :@0.519054:0.084927:0.928009:0.084927:0.928009:0.069144:0.519054:0.069144:0.004551:0.009827:0.010311:0.009903:0.004551:0.005125:0.005866:0.004188:0.004127:0.010311:0.009192:0.005125:0.004143:0.010326:0.003024:0.005866:0.009903:0.004143:0.010311:0.008104:0.004143:0.003024:0.014182:0.010311:0.004551:0.009903:0.008376:0.009827:0.010357:0.004143:0.009903:0.004551:0.004143:0.005866:0.005125:0.010326:0.010311:0.003024:0.003024:0.003024:0.005866:0.009827:0.010357:0.004158:0.013894:0.013894:0.007529:0.008104:0.004143:0.005866:0.009782:0.009903:0.004551:0.009827:0.005866:0.004188:0.004188
this may not be noticeable during a brief trial of treat-:@0.519054:0.099301:0.923821:0.099301:0.923821:0.083518:0.519054:0.083518:0.005125:0.009223:0.003024:0.005866:0.005413:0.014182:0.010326:0.008104:0.005413:0.009223:0.009903:0.005125:0.005413:0.010311:0.009827:0.005413:0.009223:0.009903:0.005125:0.003024:0.009782:0.009827:0.010326:0.010311:0.003024:0.009827:0.005413:0.010357:0.009192:0.004551:0.003024:0.009223:0.010175:0.005413:0.010326:0.005413:0.010311:0.004551:0.003024:0.009827:0.004747:0.005413:0.005125:0.004551:0.003024:0.010326:0.003024:0.005413:0.009903:0.004747:0.005413:0.005125:0.004551:0.009827:0.010326:0.005171:0.005020
ment. There fore, a reasonable approach is a six-month :@0.519054:0.113675:0.928009:0.113675:0.928009:0.097892:0.519054:0.097892:0.014182:0.009827:0.009223:0.005125:0.004188:0.004687:0.006441:0.009223:0.009827:0.004551:0.009827:0.000000:0.004747:0.009903:0.004551:0.009827:0.004188:0.004687:0.010326:0.004702:0.004551:0.009827:0.010326:0.005866:0.009903:0.009223:0.010326:0.010311:0.003024:0.009827:0.004702:0.010326:0.010311:0.010311:0.004551:0.009903:0.010326:0.009782:0.009223:0.004687:0.003024:0.005866:0.004702:0.010326:0.004702:0.005866:0.003024:0.007257:0.005020:0.014182:0.009903:0.009223:0.005125:0.009223:0.004188
trial on the recommended or maximum tolerated dose; :@0.519054:0.128049:0.927994:0.128049:0.927994:0.112266:0.519054:0.112266:0.005125:0.004551:0.003024:0.010326:0.003024:0.004067:0.009903:0.009223:0.004052:0.005125:0.009223:0.009827:0.004052:0.004551:0.009827:0.009782:0.009888:0.014182:0.014182:0.009827:0.009223:0.010357:0.009827:0.010357:0.004052:0.009903:0.004551:0.004052:0.014182:0.010326:0.007257:0.003024:0.014182:0.009192:0.014182:0.004067:0.005125:0.009903:0.003024:0.009827:0.004551:0.010326:0.005125:0.009827:0.010357:0.004052:0.010357:0.009903:0.005866:0.009827:0.004188:0.004188
if there is no evidence of improvement on bedside test-:@0.519054:0.142423:0.923806:0.142423:0.923806:0.126640:0.519054:0.126640:0.003024:0.004747:0.004158:0.005125:0.009223:0.009827:0.004551:0.009827:0.004143:0.003024:0.005866:0.004158:0.009223:0.009903:0.004143:0.009827:0.008376:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.004143:0.009903:0.004747:0.004143:0.003024:0.014182:0.010311:0.004551:0.009903:0.008376:0.009827:0.014182:0.009827:0.009223:0.005125:0.004143:0.009903:0.009223:0.004143:0.010311:0.009827:0.010357:0.005866:0.003024:0.010357:0.009827:0.004158:0.005125:0.009827:0.005866:0.005125:0.005020
ing or from carers, the medication should be discontin-:@0.519054:0.156797:0.923821:0.156797:0.923821:0.141015:0.519054:0.141015:0.003024:0.009223:0.010175:0.004778:0.009903:0.004551:0.004778:0.004747:0.004551:0.009903:0.014182:0.004778:0.009782:0.010326:0.004551:0.009827:0.004551:0.005866:0.004188:0.004778:0.005125:0.009223:0.009827:0.004778:0.014182:0.009827:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004778:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004778:0.010311:0.009827:0.004778:0.010357:0.003024:0.005866:0.009782:0.009903:0.009223:0.005125:0.003024:0.009223:0.005020
ued. Length of pharmacotherapy in treatment respon-:@0.519054:0.171171:0.923821:0.171171:0.923821:0.155389:0.519054:0.155389:0.009192:0.009827:0.010357:0.004188:0.004944:0.006985:0.009827:0.009223:0.010175:0.005125:0.009223:0.004944:0.009903:0.004747:0.004944:0.010311:0.009223:0.010326:0.004551:0.014182:0.010326:0.009782:0.009903:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004944:0.003024:0.009223:0.004944:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004944:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.005020
ders  must  be  individualised, but  the  cholinesterase :@0.519054:0.185545:0.927979:0.185545:0.927979:0.169763:0.519054:0.169763:0.010357:0.009827:0.004551:0.005866:0.004188:0.006184:0.014182:0.009192:0.005866:0.005125:0.004188:0.006184:0.010311:0.009827:0.004188:0.006184:0.003024:0.009223:0.010357:0.003024:0.008376:0.003024:0.010357:0.009192:0.010326:0.003024:0.003024:0.005866:0.009827:0.010357:0.004188:0.010387:0.010311:0.009192:0.005125:0.004188:0.006184:0.005125:0.009223:0.009827:0.004188:0.006184:0.009782:0.009223:0.009903:0.003024:0.003024:0.009223:0.009827:0.005866:0.005125:0.009827:0.004551:0.010326:0.005866:0.009827:0.004188
inhibitors certainly improve cognitive and global func-:@0.519054:0.199919:0.923806:0.199919:0.923806:0.184137:0.519054:0.184137:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.005866:0.009782:0.009827:0.004551:0.005125:0.010326:0.003024:0.009223:0.003024:0.008104:0.005881:0.003024:0.014182:0.010311:0.004551:0.009903:0.008376:0.009827:0.005866:0.009782:0.009903:0.010175:0.009223:0.003024:0.005125:0.003024:0.008376:0.009827:0.005866:0.010326:0.009223:0.010357:0.005866:0.010175:0.003024:0.009903:0.010311:0.010326:0.003024:0.005881:0.004747:0.009192:0.009223:0.009782:0.005020
tioning for up to at least six months of treatment, and :@0.519054:0.214294:0.927994:0.214294:0.927994:0.198511:0.519054:0.198511:0.005125:0.003024:0.009903:0.009223:0.003024:0.009223:0.010175:0.006002:0.004747:0.009903:0.004551:0.005987:0.009192:0.010311:0.006002:0.005125:0.009903:0.006002:0.010326:0.005125:0.006002:0.003024:0.009827:0.010326:0.005866:0.005125:0.006002:0.005866:0.003024:0.007257:0.006002:0.014182:0.009903:0.009223:0.005125:0.009223:0.005866:0.005987:0.009903:0.004747:0.006002:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.005987:0.010326:0.009223:0.010357:0.004188
perhaps in certain cases even longer.  :@0.519054:0.228668:0.808205:0.228729:0.808205:0.212946:0.519054:0.212885:0.010311:0.009827:0.004551:0.009223:0.010326:0.010311:0.005866:0.004188:0.003024:0.009223:0.004188:0.009782:0.009827:0.004551:0.005125:0.010326:0.003024:0.009223:0.004188:0.009782:0.010326:0.005866:0.009827:0.005866:0.004188:0.009827:0.008376:0.009827:0.009223:0.004188:0.003024:0.009903:0.009223:0.010175:0.009827:0.004551:0.004188:0.009691:0.226648
44:@0.794298:0.223430:0.804014:0.223430:0.804014:0.214276:0.794298:0.214276:0.004858:0.004858
steP 5: OPtimise DOse AnD DurAtiOn:@0.519047:0.261856:0.856840:0.261856:0.856840:0.241691:0.519047:0.241691:0.009609:0.007761:0.009609:0.010348:0.005174:0.010348:0.005174:0.005174:0.015522:0.010348:0.007761:0.005174:0.016631:0.005174:0.009609:0.009609:0.005174:0.012935:0.015522:0.009609:0.009609:0.005174:0.013674:0.013674:0.012935:0.005174:0.012935:0.011826:0.010718:0.013674:0.007761:0.005174:0.015522:0.013674
It is important to optimise the dose and duration of cho-:@0.519047:0.278013:0.923799:0.278013:0.923799:0.262231:0.519047:0.262231:0.003417:0.005125:0.003901:0.003024:0.005866:0.003901:0.003024:0.014182:0.010311:0.009903:0.004551:0.005125:0.010326:0.009223:0.005125:0.003886:0.005125:0.009903:0.003886:0.009903:0.010311:0.005125:0.003024:0.014182:0.003024:0.005866:0.009827:0.003901:0.005125:0.009223:0.009827:0.003886:0.010357:0.009903:0.005866:0.009827:0.003901:0.010326:0.009223:0.010357:0.003901:0.010357:0.009192:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.003886:0.009903:0.004747:0.003901:0.009782:0.009223:0.009903:0.005020
linesterase  inhibitor  treatment.  The  benefits  of  higher :@0.519047:0.292387:0.928017:0.292387:0.928017:0.276605:0.519047:0.276605:0.003024:0.003024:0.009223:0.009827:0.005866:0.005125:0.009827:0.004551:0.010326:0.005866:0.009827:0.004188:0.004097:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.004188:0.004097:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009207:0.005125:0.004188:0.004188:0.004097:0.006441:0.009223:0.009827:0.004188:0.004082:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.005866:0.004188:0.004097:0.009903:0.004747:0.004188:0.004097:0.009223:0.003024:0.010175:0.009223:0.009827:0.004551:0.004188
dosing are inconsistent, and may compromise drug tol-:@0.519047:0.306762:0.923799:0.306762:0.923799:0.290979:0.519047:0.290979:0.010357:0.009903:0.005866:0.003024:0.009223:0.010175:0.004385:0.010326:0.004551:0.009827:0.004385:0.003024:0.009223:0.009782:0.009903:0.009223:0.005866:0.003024:0.005866:0.005125:0.009827:0.009223:0.005125:0.004188:0.004385:0.010326:0.009223:0.010357:0.004385:0.014182:0.010326:0.008104:0.004400:0.009782:0.009903:0.014182:0.010311:0.004551:0.009903:0.014182:0.003024:0.005866:0.009827:0.004385:0.010357:0.004551:0.009192:0.010175:0.004385:0.005125:0.009903:0.003024:0.005020
erability.:@0.519047:0.321136:0.580552:0.321136:0.580552:0.305353:0.519047:0.305353:0.009827:0.004551:0.010326:0.010311:0.003024:0.003024:0.003024:0.005125:0.008104:0.004188
45-47:@0.580557:0.315854:0.602901:0.315854:0.602901:0.306700:0.580557:0.306700:0.004858:0.004858:0.002911:0.004858:0.004858
 As above, an ade quate trial period of six :@0.602908:0.321152:0.927997:0.321152:0.927997:0.305370:0.602908:0.305370:0.006410:0.011188:0.005866:0.006410:0.010326:0.010311:0.009903:0.008376:0.009827:0.004188:0.006410:0.010326:0.009223:0.006410:0.010326:0.010357:0.009827:0.000000:0.010311:0.009192:0.010326:0.005125:0.009827:0.006410:0.005125:0.004551:0.003024:0.010326:0.003024:0.006410:0.010311:0.009827:0.004551:0.003024:0.009903:0.010357:0.006410:0.009903:0.004747:0.006395:0.005866:0.003024:0.007257:0.004188
months at a therapeutic dose is recommended.:@0.519042:0.335526:0.870832:0.335526:0.870832:0.319744:0.519042:0.319744:0.014182:0.009903:0.009223:0.005125:0.009223:0.005866:0.004188:0.010326:0.005125:0.004188:0.010326:0.004188:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.009827:0.009192:0.005125:0.003024:0.009782:0.004188:0.010357:0.009903:0.005866:0.009827:0.004188:0.003024:0.005866:0.004188:0.004551:0.009827:0.009782:0.009903:0.014182:0.014182:0.009827:0.009223:0.010357:0.009827:0.010357:0.004188
Donepezil is administered once daily, beginning with :@0.533330:0.349901:0.927982:0.349901:0.927982:0.334118:0.533330:0.334118:0.011249:0.009903:0.009223:0.009827:0.010311:0.009827:0.006426:0.003024:0.003024:0.005201:0.003024:0.005866:0.005201:0.010326:0.010357:0.014182:0.003024:0.009223:0.003024:0.005866:0.005125:0.009827:0.004551:0.009827:0.010357:0.005201:0.009903:0.009223:0.009782:0.009827:0.005186:0.010357:0.010326:0.003024:0.003024:0.008104:0.004188:0.005201:0.010311:0.009827:0.010175:0.003024:0.009223:0.009223:0.003024:0.009223:0.010175:0.005186:0.012564:0.003024:0.005125:0.009223:0.004188
a dose  of  5 mg  at  bedtime and increasing  to  10 mg :@0.519042:0.364275:0.927982:0.364275:0.927982:0.348492:0.519042:0.348492:0.010326:0.006547:0.010357:0.009903:0.005866:0.009827:0.004188:0.002343:0.009903:0.004747:0.004188:0.002343:0.008376:0.006547:0.014182:0.010175:0.004188:0.002343:0.010326:0.005125:0.004188:0.002343:0.010311:0.009827:0.010357:0.005125:0.003024:0.014182:0.009827:0.006547:0.010326:0.009223:0.010357:0.006547:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.003024:0.009223:0.010175:0.004188:0.002343:0.005125:0.009903:0.004188:0.002343:0.008376:0.008376:0.006547:0.014182:0.010175:0.004188
after four weeks (particularly in patients weighing more :@0.519042:0.378649:0.927997:0.378649:0.927997:0.362866:0.519042:0.362866:0.010326:0.004747:0.005125:0.009827:0.004551:0.004626:0.004747:0.009903:0.009192:0.004551:0.004626:0.012564:0.009827:0.009827:0.007590:0.005866:0.004626:0.005579:0.010311:0.010326:0.004551:0.005125:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.003024:0.008104:0.004642:0.003024:0.009223:0.004642:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004642:0.012564:0.009827:0.003024:0.010175:0.009223:0.003024:0.009223:0.010175:0.004626:0.014182:0.009903:0.004551:0.009827:0.004188
than  60  kg).  Rivastigmine is initiated at  1.5  mg  twice :@0.519042:0.393023:0.927967:0.393023:0.927967:0.377240:0.519042:0.377240:0.005125:0.009223:0.010326:0.009223:0.004188:0.003160:0.008376:0.008376:0.004188:0.003160:0.007590:0.010175:0.005579:0.004188:0.004188:0.003160:0.009177:0.003024:0.008376:0.010326:0.005866:0.005125:0.003024:0.010175:0.014182:0.003024:0.009223:0.009827:0.007363:0.003024:0.005866:0.007363:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.005125:0.009827:0.010357:0.007363:0.010326:0.005125:0.004188:0.003160:0.008376:0.004188:0.008376:0.004188:0.003175:0.014182:0.010175:0.004188:0.003160:0.005125:0.012564:0.003024:0.009782:0.009827:0.004188
daily, and increased by 1.5 mg twice daily every two to :@0.519042:0.407397:0.927982:0.407397:0.927982:0.391614:0.519042:0.391614:0.010357:0.010326:0.003024:0.003024:0.008104:0.004188:0.004097:0.010326:0.009223:0.010357:0.004082:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.004082:0.010311:0.008104:0.004082:0.008376:0.004188:0.008376:0.004097:0.014182:0.010175:0.004082:0.005125:0.012564:0.003024:0.009782:0.009827:0.004082:0.010357:0.010326:0.003024:0.003024:0.008104:0.004097:0.009827:0.008376:0.009827:0.004551:0.008104:0.004082:0.005125:0.012564:0.009903:0.004082:0.005125:0.009903:0.004188
four weeks to a maximum of 12 mg daily. If treatment is :@0.519042:0.421771:0.927982:0.421771:0.927982:0.405988:0.519042:0.405988:0.004747:0.009903:0.009192:0.004551:0.004339:0.012564:0.009827:0.009827:0.007590:0.005866:0.004354:0.005125:0.009903:0.004339:0.010326:0.004354:0.014182:0.010326:0.007257:0.003024:0.014182:0.009192:0.014182:0.004354:0.009903:0.004747:0.004339:0.008376:0.008376:0.004354:0.014182:0.010175:0.004354:0.010357:0.010326:0.003024:0.003024:0.008104:0.004188:0.004354:0.003417:0.004747:0.004354:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004339:0.003024:0.005866:0.004188
missed for more than three days, it should be restarted :@0.519042:0.436145:0.927982:0.436145:0.927982:0.420362:0.519042:0.420362:0.014182:0.003024:0.005866:0.005866:0.009827:0.010357:0.005035:0.004747:0.009903:0.004551:0.005020:0.014182:0.009903:0.004551:0.009812:0.005035:0.005125:0.009223:0.010326:0.009223:0.005035:0.005125:0.009223:0.004551:0.009827:0.009827:0.005020:0.010357:0.010326:0.008104:0.005866:0.004188:0.005035:0.003024:0.005125:0.005035:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005035:0.010311:0.009827:0.005035:0.004551:0.009827:0.005866:0.005125:0.010326:0.004551:0.005125:0.009827:0.010357:0.004188
at the lowest daily dose and retitrated up. Galantamine :@0.519042:0.450519:0.927982:0.450519:0.927982:0.434737:0.519042:0.434737:0.010326:0.005125:0.003598:0.005125:0.009223:0.009827:0.003598:0.003024:0.009903:0.012564:0.009827:0.005866:0.005125:0.003598:0.010357:0.010326:0.003024:0.003024:0.008104:0.003613:0.010357:0.009903:0.005866:0.009827:0.003598:0.010326:0.009223:0.010357:0.003598:0.004551:0.009827:0.005125:0.003024:0.005125:0.004551:0.010326:0.005125:0.009827:0.010357:0.003598:0.009192:0.010311:0.004188:0.003598:0.013184:0.010326:0.003024:0.010326:0.009223:0.005125:0.010326:0.014182:0.003024:0.009223:0.009827:0.004188
ER (extended  release) is initiated  at  8 mg  daily, and :@0.519042:0.464893:0.927982:0.464893:0.927982:0.449111:0.519042:0.449111:0.008104:0.009177:0.007363:0.005579:0.009827:0.007257:0.005125:0.009827:0.009223:0.010357:0.009827:0.010357:0.004188:0.003160:0.004551:0.009827:0.003024:0.009827:0.010326:0.005866:0.009827:0.005579:0.007363:0.003024:0.005866:0.007363:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.005125:0.009827:0.010357:0.004188:0.003160:0.010326:0.005125:0.004188:0.003160:0.008376:0.007363:0.014182:0.010175:0.004188:0.003160:0.010357:0.010326:0.003024:0.003024:0.008104:0.004188:0.007363:0.010326:0.009223:0.010357:0.004188
dose is increased to a minimum maintenance dosage :@0.519042:0.479267:0.927982:0.479267:0.927982:0.463485:0.519042:0.463485:0.010357:0.009903:0.005866:0.009827:0.005458:0.003024:0.005866:0.005473:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.005458:0.005125:0.009903:0.005458:0.010326:0.005458:0.014182:0.003024:0.009223:0.003024:0.014182:0.009192:0.014182:0.005458:0.014182:0.010326:0.003024:0.009223:0.005125:0.009827:0.009223:0.010326:0.009223:0.009782:0.009827:0.005458:0.010357:0.009903:0.005866:0.010326:0.010175:0.009827:0.004188
of 16 mg daily after a minimum of four weeks. similarly, if :@0.519042:0.493641:0.927997:0.493641:0.927997:0.477859:0.519042:0.477859:0.009903:0.004747:0.003689:0.008376:0.008376:0.003689:0.014182:0.010175:0.003689:0.010357:0.010326:0.003024:0.003024:0.008104:0.003704:0.010326:0.004747:0.005125:0.009827:0.004551:0.003689:0.010326:0.003689:0.014182:0.003024:0.009223:0.003024:0.014182:0.009192:0.014182:0.003689:0.009903:0.004747:0.003689:0.004747:0.009903:0.009192:0.004551:0.003689:0.012564:0.009827:0.009827:0.007590:0.005866:0.004188:0.003689:0.007529:0.003024:0.014182:0.003024:0.003024:0.010326:0.004551:0.003024:0.008104:0.004188:0.003704:0.003024:0.004747:0.004188
missed for more than several days, it should be restarted :@0.519042:0.508015:0.927967:0.508015:0.927967:0.492233:0.519042:0.492233:0.014182:0.003024:0.005866:0.005866:0.009827:0.010357:0.003568:0.004747:0.009903:0.004551:0.003553:0.014182:0.009903:0.004551:0.009812:0.003553:0.005125:0.009223:0.010326:0.009223:0.003553:0.005866:0.009827:0.008376:0.009827:0.004551:0.010326:0.003024:0.003568:0.010357:0.010326:0.008104:0.005866:0.004188:0.003568:0.003024:0.005125:0.003553:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.003553:0.010311:0.009827:0.003553:0.004551:0.009827:0.005866:0.005125:0.010326:0.004551:0.005125:0.009827:0.010357:0.004188
at the lowest dose and titrated up to the current dose.:@0.519042:0.522390:0.917278:0.522390:0.917278:0.506607:0.519042:0.506607:0.010326:0.005125:0.004188:0.005125:0.009223:0.009827:0.004188:0.003024:0.009903:0.012564:0.009827:0.005866:0.005125:0.004188:0.010357:0.009903:0.005866:0.009827:0.004188:0.010326:0.009223:0.010357:0.004188:0.005125:0.003024:0.005125:0.004551:0.010326:0.005125:0.009827:0.010357:0.004188:0.009192:0.010311:0.004188:0.005125:0.009903:0.004188:0.005125:0.009223:0.009827:0.004188:0.009782:0.009192:0.004551:0.004551:0.009827:0.009223:0.005125:0.004188:0.010357:0.009903:0.005866:0.009827:0.004188
Caution  is needed  when  prescribing  these  agents :@0.533330:0.536764:0.927982:0.536764:0.927982:0.520981:0.533330:0.520981:0.012292:0.010326:0.009192:0.005125:0.003024:0.009903:0.009223:0.004188:0.004339:0.003024:0.005866:0.008542:0.009223:0.009827:0.009827:0.010357:0.009827:0.010357:0.004188:0.004339:0.012564:0.009223:0.009827:0.009223:0.004188:0.004339:0.010311:0.004551:0.009827:0.005866:0.009782:0.004551:0.003024:0.010311:0.003024:0.009223:0.010175:0.004188:0.004339:0.005125:0.009223:0.009827:0.005866:0.009827:0.004188:0.004339:0.010326:0.010175:0.009827:0.009223:0.005125:0.005866:0.004188
to patients with sick sinus syndrome or other supraven-:@0.519042:0.551138:0.923779:0.551138:0.923779:0.535355:0.519042:0.535355:0.005125:0.009903:0.005458:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005473:0.012564:0.003024:0.005125:0.009223:0.005473:0.005866:0.003024:0.009782:0.007590:0.005473:0.005866:0.003024:0.009223:0.009192:0.005866:0.005473:0.005866:0.008104:0.009223:0.010357:0.004551:0.009903:0.014182:0.009827:0.005458:0.009903:0.004551:0.005458:0.009903:0.005125:0.009223:0.009827:0.004551:0.005458:0.005866:0.009192:0.010311:0.004551:0.010326:0.008376:0.009827:0.009223:0.005020
tricular con duction defects, or when combining agents :@0.519042:0.565512:0.927997:0.565512:0.927997:0.549729:0.519042:0.549729:0.005125:0.004551:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.004218:0.009782:0.009903:0.009223:0.000000:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004218:0.010357:0.009827:0.004747:0.009827:0.009782:0.005125:0.005866:0.004188:0.004218:0.009903:0.004551:0.004203:0.012564:0.009223:0.009827:0.009223:0.004218:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.003024:0.009223:0.010175:0.004218:0.010326:0.010175:0.009827:0.009223:0.005125:0.005866:0.004188
metabolised by the  p450 system  (donepezil,  galan-:@0.519042:0.579886:0.923799:0.579988:0.923799:0.564205:0.519042:0.564103:0.014182:0.009827:0.005125:0.010326:0.010311:0.009903:0.003024:0.003024:0.005866:0.009827:0.010357:0.009601:0.010311:0.008104:0.009601:0.005125:0.009223:0.009827:0.004188:0.005397:0.008950:0.008376:0.008376:0.008376:0.009601:0.005866:0.008104:0.005871:0.005125:0.009827:0.014182:0.004188:0.005397:0.005579:0.010357:0.009903:0.009223:0.009827:0.010311:0.009827:0.006426:0.003024:0.003024:0.004188:0.004188:0.005397:0.010175:0.010326:0.003024:0.010326:0.009223:-0.348095
 :@0.745712:0.574689:0.748141:0.574689:0.748141:0.565535:0.745712:0.565535:0.002429
tamine) with  other  medications metabolised by this :@0.519047:0.594362:0.928002:0.594362:0.928002:0.578579:0.519047:0.578579:0.005125:0.010326:0.014182:0.003024:0.009223:0.009827:0.005579:0.009147:0.012564:0.003024:0.005125:0.009223:0.004188:0.004944:0.009903:0.005125:0.009223:0.009827:0.004551:0.004188:0.004944:0.014182:0.009827:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.009147:0.014182:0.009827:0.005125:0.010326:0.010311:0.009903:0.003024:0.003024:0.005866:0.009827:0.010357:0.009147:0.010311:0.008104:0.009147:0.005125:0.009223:0.003024:0.005866:0.004188
pathway.  :@0.519047:0.608736:0.603124:0.608747:0.603124:0.592964:0.519047:0.592953:0.010311:0.010326:0.005125:0.009223:0.012564:0.010326:0.008104:0.004188:0.009722:-0.065913
48:@0.589216:0.603448:0.598933:0.603448:0.598933:0.594294:0.589216:0.594294:0.004858:0.004858
steP 6: mAintenAnCe Of treAtment:@0.519047:0.641874:0.845753:0.641874:0.845753:0.621709:0.519047:0.621709:0.009609:0.007761:0.009609:0.010348:0.005174:0.010348:0.005174:0.005174:0.016631:0.013674:0.005174:0.013674:0.007761:0.009609:0.013674:0.013674:0.013674:0.014413:0.009609:0.005174:0.015522:0.008870:0.005174:0.007761:0.010718:0.009609:0.013674:0.007761:0.016631:0.009609:0.013674:0.007761
Reassess the patient at the end of a clinical trial of opti-:@0.519047:0.658032:0.923784:0.658032:0.923784:0.642249:0.519047:0.642249:0.009177:0.009827:0.010326:0.005866:0.005866:0.009827:0.005866:0.005866:0.004158:0.005125:0.009223:0.009827:0.004143:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.004158:0.010326:0.005125:0.004158:0.005125:0.009223:0.009827:0.004143:0.009827:0.009223:0.010357:0.004158:0.009903:0.004747:0.004143:0.010326:0.004158:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004158:0.005125:0.004551:0.003024:0.010326:0.003024:0.004158:0.009903:0.004747:0.004143:0.009903:0.010311:0.005125:0.003024:0.005020
mal dose and duration. Data obtained at the two-year :@0.519047:0.672406:0.927987:0.672406:0.927987:0.656623:0.519047:0.656623:0.014182:0.010326:0.003024:0.004415:0.010357:0.009903:0.005866:0.009827:0.004415:0.010326:0.009223:0.010357:0.004415:0.010357:0.009192:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004400:0.011249:0.010326:0.005125:0.010326:0.004415:0.009903:0.010311:0.005125:0.010326:0.003024:0.009223:0.009827:0.010357:0.004415:0.010326:0.005125:0.004415:0.005125:0.009223:0.009827:0.004415:0.005125:0.012564:0.009903:0.005020:0.008104:0.009827:0.010326:0.004551:0.004188
mark shows that  some patients are still functioning  at :@0.519047:0.686780:0.928002:0.686780:0.928002:0.670997:0.519047:0.670997:0.014182:0.010326:0.004551:0.007590:0.006683:0.005866:0.009223:0.009903:0.012564:0.005866:0.006683:0.005125:0.009223:0.010326:0.005125:0.004188:0.002480:0.005866:0.009903:0.014182:0.009827:0.006683:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006683:0.010326:0.004551:0.009827:0.006683:0.005866:0.005125:0.003024:0.003024:0.003024:0.006683:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.003024:0.009223:0.010175:0.004188:0.002480:0.010326:0.005125:0.004188
above their expected level of deterioration when com-:@0.519047:0.701154:0.923799:0.701154:0.923799:0.685371:0.519047:0.685371:0.010326:0.010311:0.009903:0.008376:0.009827:0.004112:0.005125:0.009223:0.009827:0.003024:0.004551:0.004097:0.009827:0.007257:0.010311:0.009827:0.009782:0.005125:0.009827:0.010357:0.004097:0.003024:0.009827:0.008376:0.009827:0.003024:0.004112:0.009903:0.004747:0.004112:0.010357:0.009827:0.005125:0.009827:0.004551:0.003024:0.009903:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004097:0.012564:0.009223:0.009827:0.009223:0.004097:0.009782:0.009903:0.014182:0.005020
pared with untreated patients.  Unfortunately, response :@0.519047:0.715528:0.927997:0.715551:0.927997:0.699768:0.519047:0.699745:0.010311:0.010326:0.004551:0.009827:0.010357:0.003069:0.012564:0.003024:0.005125:0.009223:0.003069:0.009192:0.009223:0.005125:0.004536:0.009827:0.010326:0.005125:0.009827:0.010357:0.003069:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.009731:0.003069:0.009903:0.009223:0.004747:0.009903:0.004551:0.005125:0.009192:0.009223:0.010326:0.005125:0.009827:0.003024:0.008104:0.004188:0.003054:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.005866:0.009827:-0.530648
49:@0.740130:0.710252:0.749846:0.710252:0.749846:0.701098:0.740130:0.701098:0.004858:0.004858
table 2. Criteria for major neurocognitive disorder due to Alzheimer’s disease (adapted from Dsm-5):@0.076190:0.750314:0.806137:0.750314:0.806137:0.733815:0.076190:0.733815:0.006350:0.009979:0.009979:0.003629:0.009676:0.004233:0.008467:0.004233:0.004233:0.011793:0.004838:0.003629:0.004536:0.009676:0.004838:0.003629:0.009979:0.004233:0.004233:0.009676:0.004838:0.004233:0.014212:0.009979:0.003931:0.009676:0.004838:0.004233:0.009071:0.009676:0.009071:0.004838:0.009676:0.009676:0.009676:0.009979:0.009071:0.003629:0.004536:0.003629:0.008467:0.009676:0.004233:0.009979:0.003629:0.006652:0.009676:0.004838:0.009979:0.009676:0.004838:0.004233:0.009979:0.009071:0.009676:0.004233:0.004536:0.009676:0.004233:0.011188:0.003629:0.006955:0.009071:0.009676:0.003629:0.014212:0.009676:0.004838:0.004233:0.006652:0.004233:0.009979:0.003629:0.006652:0.009676:0.009979:0.006652:0.009676:0.004233:0.005745:0.009979:0.009979:0.009979:0.009979:0.004536:0.009676:0.009979:0.004233:0.004233:0.004838:0.009676:0.014212:0.004233:0.010583:0.007862:0.013607:0.006350:0.008467:0.005745
A.  The criteria are met for major neurocognitive disorder.:@0.083750:0.769651:0.457372:0.769651:0.457372:0.755622:0.083750:0.755622:0.009945:0.003723:0.003723:0.006128:0.005725:0.008198:0.008735:0.003723:0.008695:0.004045:0.002688:0.004556:0.008735:0.004045:0.002688:0.009179:0.003723:0.009179:0.004045:0.008735:0.003723:0.012606:0.008735:0.004556:0.003723:0.004220:0.008803:0.004045:0.003723:0.012606:0.009179:0.002728:0.008803:0.004045:0.003723:0.008198:0.008735:0.008171:0.004045:0.008803:0.008695:0.008803:0.009045:0.008198:0.002688:0.004556:0.002688:0.007445:0.008735:0.003723:0.009206:0.002688:0.005214:0.008803:0.004045:0.009206:0.008735:0.004045:0.003723
B.  There is insidious onset and gradual progression of impairments.:@0.083750:0.787610:0.517243:0.787610:0.517243:0.773581:0.083750:0.773581:0.007714:0.003723:0.003723:0.008359:0.005725:0.008198:0.008735:0.004045:0.008735:0.003723:0.002688:0.005214:0.003723:0.002688:0.008198:0.005214:0.002688:0.009206:0.002688:0.008803:0.008171:0.005214:0.003723:0.008803:0.008198:0.005214:0.008735:0.004556:0.003723:0.009179:0.008198:0.009206:0.003723:0.009045:0.004045:0.009179:0.009206:0.008171:0.009179:0.002688:0.003723:0.009165:0.004045:0.008803:0.009045:0.004045:0.008735:0.005214:0.005214:0.002688:0.008803:0.008198:0.003723:0.008803:0.004220:0.003723:0.002688:0.012606:0.009165:0.009179:0.002688:0.004045:0.012606:0.008735:0.008198:0.004556:0.005214:0.003723
C.  Criteria are met for either probable or possible Alzheimer’s disease.:@0.083750:0.805570:0.540963:0.805570:0.540963:0.791541:0.083750:0.791541:0.010926:0.003723:0.003723:0.005147:0.010926:0.004045:0.002688:0.004556:0.008735:0.004045:0.002688:0.009179:0.003723:0.009179:0.004045:0.008735:0.003723:0.012606:0.008735:0.004556:0.003723:0.004220:0.008803:0.004045:0.003723:0.008735:0.002688:0.004556:0.008198:0.008735:0.004045:0.003723:0.009165:0.004045:0.008803:0.009165:0.009179:0.009165:0.002688:0.008735:0.003723:0.008803:0.004045:0.003723:0.009165:0.008803:0.005214:0.005214:0.002688:0.009165:0.002688:0.008735:0.003723:0.009945:0.002688:0.005712:0.008198:0.008735:0.002688:0.012606:0.008735:0.004045:0.004717:0.005214:0.003723:0.009206:0.002688:0.005214:0.008735:0.009179:0.005214:0.008735:0.003723
 :@0.083750:0.818398:0.087513:0.818398:0.087513:0.803733:0.083750:0.803733:0.003763
Probable Alzheimer’s disease:@0.107268:0.818398:0.296707:0.818398:0.296707:0.804369:0.107268:0.804369:0.007956:0.004045:0.008803:0.009165:0.009179:0.009165:0.002688:0.008735:0.003723:0.009945:0.002688:0.005712:0.008198:0.008735:0.002688:0.012606:0.008735:0.004045:0.004717:0.005214:0.003723:0.009206:0.002688:0.005214:0.008735:0.009179:0.005214:0.008735
 is diagnosed if either of the following is present (otherwise :@0.296707:0.818398:0.676161:0.818398:0.676161:0.804369:0.296707:0.804369:0.003723:0.002688:0.005214:0.003723:0.009206:0.002688:0.009179:0.009045:0.008198:0.008803:0.005214:0.008735:0.009206:0.003723:0.002688:0.004220:0.003723:0.008735:0.002688:0.004556:0.008198:0.008735:0.004045:0.003723:0.008803:0.004220:0.003723:0.004556:0.008198:0.008735:0.003723:0.004220:0.008803:0.002688:0.002688:0.008803:0.011168:0.002688:0.008198:0.009045:0.003723:0.002688:0.005214:0.003723:0.009165:0.004045:0.008735:0.005214:0.008735:0.008198:0.004556:0.003723:0.004959:0.008803:0.004556:0.008198:0.008735:0.004045:0.011168:0.002688:0.005214:0.008735:0.003723
possible Alzheimer’s disease:@0.676120:0.818398:0.857495:0.818398:0.857495:0.804369:0.676120:0.804369:0.009165:0.008803:0.005214:0.005214:0.002688:0.009165:0.002688:0.008735:0.003723:0.009945:0.002688:0.005712:0.008198:0.008735:0.002688:0.012606:0.008735:0.004045:0.004717:0.005214:0.003723:0.009206:0.002688:0.005214:0.008735:0.009179:0.005214:0.008735
 should :@0.857509:0.818398:0.907233:0.818398:0.907233:0.804369:0.857509:0.804369:0.003723:0.005214:0.008198:0.008803:0.008171:0.002688:0.009206:0.003723
be diagnosed)::@0.107268:0.831226:0.207847:0.831226:0.207847:0.817197:0.107268:0.817197:0.009165:0.008735:0.003723:0.009206:0.002688:0.009179:0.009045:0.008198:0.008803:0.005214:0.008735:0.009206:0.004959:0.003723
(1)  Evidence of a causative Alzheimer’s disease genetic mutation from family history or genetic testing.:@0.134147:0.844055:0.810593:0.844055:0.810593:0.830026:0.134147:0.830026:0.004959:0.007445:0.004959:0.003723:0.009152:0.007203:0.007445:0.002688:0.009206:0.008735:0.008198:0.008695:0.008735:0.003723:0.008803:0.004220:0.003723:0.009179:0.003723:0.008695:0.009179:0.008171:0.005214:0.009179:0.004556:0.002688:0.007445:0.008735:0.003723:0.009945:0.002688:0.005712:0.008198:0.008735:0.002688:0.012606:0.008735:0.004045:0.004717:0.005214:0.003723:0.009206:0.002688:0.005214:0.008735:0.009179:0.005214:0.008735:0.003723:0.009045:0.008735:0.008198:0.008735:0.004556:0.002688:0.008695:0.003723:0.012606:0.008171:0.004556:0.009179:0.004556:0.002688:0.008803:0.008198:0.003723:0.004220:0.004045:0.008803:0.012606:0.003723:0.004220:0.009179:0.012606:0.002688:0.002688:0.007203:0.003723:0.008198:0.002688:0.005214:0.004556:0.008803:0.004045:0.007203:0.003723:0.008803:0.004045:0.003723:0.009045:0.008735:0.008198:0.008735:0.004556:0.002688:0.008695:0.003723:0.004556:0.008735:0.005214:0.004556:0.002688:0.008198:0.009045:0.003723
(2)  All three of the following are present::@0.134147:0.856883:0.403454:0.856883:0.403454:0.842854:0.134147:0.842854:0.004959:0.007445:0.004959:0.003723:0.009152:0.009945:0.002688:0.002688:0.003723:0.004556:0.008198:0.004045:0.008735:0.008735:0.003723:0.008803:0.004220:0.003723:0.004556:0.008198:0.008735:0.003723:0.004220:0.008803:0.002688:0.002688:0.008803:0.011168:0.002688:0.008198:0.009045:0.003723:0.009179:0.004045:0.008735:0.003723:0.009165:0.004045:0.008735:0.005214:0.008735:0.008198:0.004556:0.003723
a. :@0.164385:0.869711:0.181009:0.869711:0.181009:0.855682:0.164385:0.855682:0.009179:0.003723:0.003723
Clear evidence of decline in memory and learning, and at least one other neurocognitive domain.:@0.194623:0.869711:0.838653:0.869711:0.838653:0.855682:0.194623:0.855682:0.010926:0.002688:0.008735:0.009179:0.004045:0.003723:0.008735:0.007445:0.002688:0.009206:0.008735:0.008198:0.008695:0.008735:0.003723:0.008803:0.004220:0.003723:0.009206:0.008735:0.008695:0.002688:0.002688:0.008198:0.008735:0.003723:0.002688:0.008198:0.003723:0.012606:0.008735:0.012606:0.008803:0.004045:0.007203:0.003723:0.009179:0.008198:0.009206:0.003723:0.002688:0.008735:0.009179:0.004045:0.008198:0.002688:0.008198:0.009045:0.003723:0.003723:0.009179:0.008198:0.009206:0.003723:0.009179:0.004556:0.003723:0.002688:0.008735:0.009179:0.005214:0.004556:0.003723:0.008803:0.008198:0.008735:0.003723:0.008803:0.004556:0.008198:0.008735:0.004045:0.003723:0.008198:0.008735:0.008171:0.004045:0.008803:0.008695:0.008803:0.009045:0.008198:0.002688:0.004556:0.002688:0.007445:0.008735:0.003723:0.009206:0.008803:0.012606:0.009179:0.002688:0.008198:0.003723
b. :@0.164385:0.882540:0.180996:0.882540:0.180996:0.868511:0.164385:0.868511:0.009165:0.003723:0.003723
steadily progressive, gradual decline.:@0.194623:0.882540:0.437777:0.882540:0.437777:0.868511:0.194623:0.868511:0.006693:0.004556:0.008735:0.009179:0.009206:0.002688:0.002688:0.007203:0.003723:0.009165:0.004045:0.008803:0.009045:0.004045:0.008735:0.005214:0.005214:0.002688:0.007445:0.008735:0.003723:0.003723:0.009045:0.004045:0.009179:0.009206:0.008171:0.009179:0.002688:0.003723:0.009206:0.008735:0.008695:0.002688:0.002688:0.008198:0.008735:0.003723
c. :@0.164385:0.895368:0.180525:0.895368:0.180525:0.881339:0.164385:0.881339:0.008695:0.003723:0.003723
No evidence of mixed aetiology (ie, absence of other neurodegenerative or cerebrovascular disease, or :@0.194623:0.895368:0.880207:0.895368:0.880207:0.881339:0.194623:0.881339:0.009945:0.008803:0.003723:0.008735:0.007445:0.002688:0.009206:0.008735:0.008198:0.008695:0.008735:0.003723:0.008803:0.004220:0.003723:0.012606:0.002688:0.006451:0.008735:0.009206:0.003723:0.009179:0.008735:0.004556:0.002688:0.008803:0.002688:0.008803:0.009045:0.007203:0.003723:0.004959:0.002688:0.008735:0.003723:0.003723:0.009179:0.009165:0.005214:0.008735:0.008198:0.008695:0.008735:0.003723:0.008803:0.004220:0.003723:0.008803:0.004556:0.008198:0.008735:0.004045:0.003723:0.008198:0.008735:0.008171:0.004045:0.008803:0.009206:0.008735:0.009045:0.008735:0.008198:0.008735:0.004045:0.009179:0.004556:0.002688:0.007445:0.008735:0.003723:0.008803:0.004045:0.003723:0.008695:0.008735:0.004045:0.008735:0.009165:0.004045:0.008803:0.007445:0.009179:0.005214:0.008695:0.008171:0.002688:0.009179:0.004045:0.003723:0.009206:0.002688:0.005214:0.008735:0.009179:0.005214:0.008735:0.003723:0.003723:0.008803:0.004045:0.003723
another neurological, mental or systemic disease likely to contribute to cognitive decline).:@0.194623:0.908196:0.778997:0.908196:0.778997:0.894167:0.194623:0.894167:0.009179:0.008198:0.008803:0.004556:0.008198:0.008735:0.004045:0.003723:0.008198:0.008735:0.008171:0.004045:0.008803:0.002688:0.008803:0.009045:0.002688:0.008695:0.009179:0.002688:0.003723:0.003723:0.012606:0.008735:0.008198:0.004556:0.009179:0.002688:0.003723:0.008803:0.004045:0.003723:0.005214:0.007203:0.005214:0.004556:0.008735:0.012606:0.002688:0.008695:0.003723:0.009206:0.002688:0.005214:0.008735:0.009179:0.005214:0.008735:0.003723:0.002688:0.002688:0.006746:0.008735:0.002688:0.007203:0.003723:0.004556:0.008803:0.003723:0.008695:0.008803:0.008198:0.004556:0.004045:0.002688:0.009165:0.008171:0.004556:0.008735:0.003723:0.004556:0.008803:0.003723:0.008695:0.008803:0.009045:0.008198:0.002688:0.004556:0.002688:0.007445:0.008735:0.003723:0.009206:0.008735:0.008695:0.002688:0.002688:0.008198:0.008735:0.004959:0.003723
D.  The disturbance is not better explained by cerebrovascular disease, another neurodegenerative disease, the effects of a :@0.083750:0.926156:0.897275:0.926156:0.897275:0.912127:0.083750:0.912127:0.009999:0.003723:0.003723:0.006074:0.005725:0.008198:0.008735:0.003723:0.009206:0.002688:0.005214:0.004556:0.008171:0.004045:0.009165:0.009179:0.008198:0.008695:0.008735:0.003723:0.002688:0.005214:0.003723:0.008198:0.008803:0.004556:0.003723:0.009165:0.008735:0.004556:0.004556:0.008735:0.004045:0.003723:0.008735:0.006451:0.009165:0.002688:0.009179:0.002688:0.008198:0.008735:0.009206:0.003723:0.009165:0.007203:0.003723:0.008695:0.008735:0.004045:0.008735:0.009165:0.004045:0.008803:0.007445:0.009179:0.005214:0.008695:0.008171:0.002688:0.009179:0.004045:0.003723:0.009206:0.002688:0.005214:0.008735:0.009179:0.005214:0.008735:0.003723:0.003723:0.009179:0.008198:0.008803:0.004556:0.008198:0.008735:0.004045:0.003723:0.008198:0.008735:0.008171:0.004045:0.008803:0.009206:0.008735:0.009045:0.008735:0.008198:0.008735:0.004045:0.009179:0.004556:0.002688:0.007445:0.008735:0.003723:0.009206:0.002688:0.005214:0.008735:0.009179:0.005214:0.008735:0.003723:0.003723:0.004556:0.008198:0.008735:0.003723:0.008735:0.004220:0.004220:0.008735:0.008695:0.004556:0.005214:0.003723:0.008803:0.004220:0.003723:0.009179:0.003723
substance, or another mental, neurological or systemic disorder.:@0.107268:0.938984:0.523586:0.938984:0.523586:0.924955:0.107268:0.924955:0.005214:0.008171:0.009165:0.005214:0.004556:0.009179:0.008198:0.008695:0.008735:0.003723:0.003723:0.008803:0.004045:0.003723:0.009179:0.008198:0.008803:0.004556:0.008198:0.008735:0.004045:0.003723:0.012606:0.008735:0.008198:0.004556:0.009179:0.002688:0.003723:0.003723:0.008198:0.008735:0.008171:0.004045:0.008803:0.002688:0.008803:0.009045:0.002688:0.008695:0.009179:0.002688:0.003723:0.008803:0.004045:0.003723:0.005214:0.007203:0.005214:0.004556:0.008735:0.012606:0.002688:0.008695:0.003723:0.009206:0.002688:0.005214:0.008803:0.004045:0.009206:0.008735:0.004045:0.003723